Astaxanthin attenuates joint inflammation induced by monosodium urate crystals

Gouty arthritis is the one of the most painful arthritis and is caused by an inflammatory reaction. This study investigated whether astaxanthin (AXT), which has documented anti‐inflammatory and antioxidant properties, exhibits protective effects against monosodium urate (MSU) crystal‐induced inflammation. Cell viability of J774A.1 murine macrophages was assessed by AXT dose‐dependent incubation by MTT assays, and expression levels of iNOS and COX‐2 proteins as well as secretion of IL‐1β were also analyzed under MSU crystals stimulation with or without AXT treatment. The production of inflammatory mediators was found to significantly decrease with AXT treatment, and the formation of the inflammasome complex was also attenuated when cells were co‐stimulated with MSU crystals and AXT. Furthermore, we found that expression of the MAPK pathway was downregulated in J774A.1 cells. AXT also inhibited the induction of COX‐2 and IL‐6 in human chondrocytes and synovial fibroblasts by western blots. Finally, an MSU crystal intra‐articular injection rat model for gouty arthritis was utilized in which treatment groups received 5‐daily intraperitoneal injections of AXT prior to MSU crystal stimulation, or once intra‐articular injections of AXT following MSU crystal stimulation for 6 hours. Results of synovitis score analysis revealed that inflammation was significantly attenuated in the group which received intraperitoneal AXT injection prior to MSU crystal stimulation compared to the group which received MSU only. These results indicate that AXT attenuates the effects of MSU crystal‐induced inflammation by suppressing the production of pro‐inflammatory cytokines and inflammatory mediators. Our findings that the anti‐inflammatory activities of AXT may be beneficial in the treatment of MSU crystal‐induced arthritis.

[1]  Mei Zeng,et al.  Curcumin attenuates MSU crystal-induced inflammation by inhibiting the degradation of IκBα and blocking mitochondrial damage , 2019, Arthritis Research & Therapy.

[2]  S. Benkő,et al.  The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout. , 2019, Archives of biochemistry and biophysics.

[3]  E. Latz,et al.  NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis. , 2018, Circulation research.

[4]  Leou-Chyr Lin,et al.  Arthroprotective Effects of Cf-02 Sharing Structural Similarity with Quercetin , 2018, International journal of molecular sciences.

[5]  G. Yen,et al.  Beneficial Properties of Phytochemicals on NLRP3 Inflammasome-Mediated Gout and Complication. , 2018, Journal of agricultural and food chemistry.

[6]  R. Sun,et al.  Structural Differences between the Lignin-Carbohydrate Complexes (LCCs) from 2- and 24-Month-Old Bamboo (Neosinocalamus affinis) , 2017, International journal of molecular sciences.

[7]  Ashish Ranjan Sharma,et al.  Anti-inflammatory effects of traditional mixed extract of medicinal herbs (MEMH) on monosodium urate crystal-induced gouty arthritis. , 2017, Chinese journal of natural medicines.

[8]  Yi Zheng,et al.  NLRP3 Inflammasome Plays an Important Role in the Pathogenesis of Collagen-Induced Arthritis , 2016, Mediators of inflammation.

[9]  Chang-Hao Yang,et al.  Astaxanthin Inhibits Expression of Retinal Oxidative Stress and Inflammatory Mediators in Streptozotocin-Induced Diabetic Rats , 2016, PloS one.

[10]  M. Rasool,et al.  Morin, a Bioflavonoid Suppresses Monosodium Urate Crystal-Induced Inflammatory Immune Response in RAW 264.7 Macrophages through the Inhibition of Inflammatory Mediators, Intracellular ROS Levels and NF-κB Activation , 2015, PloS one.

[11]  I. Mataga,et al.  Anti-inflammatory effects of astaxanthin in the human gingival keratinocyte line NDUSD-1 , 2015, Journal of clinical biochemistry and nutrition.

[12]  Bertrand Friguet,et al.  NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases , 2015, Redox biology.

[13]  F. Perez-Ruiz,et al.  A Review of Uric Acid, Crystal Deposition Disease, and Gout , 2014, Advances in Therapy.

[14]  Leslie J Crofford,et al.  Use of NSAIDs in treating patients with arthritis , 2013, Arthritis Research & Therapy.

[15]  D. Salter,et al.  Pycnogenol attenuates the inflammatory and nitrosative stress on joint inflammation induced by urate crystals. , 2012, Free radical biology & medicine.

[16]  L. French,et al.  Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression , 2011, Proceedings of the National Academy of Sciences.

[17]  G. López-Castejón,et al.  Understanding the mechanism of IL-1β secretion , 2011, Cytokine & growth factor reviews.

[18]  Garret A. FitzGerald,et al.  Prostaglandins and Inflammation , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[19]  J. Coombes,et al.  Astaxanthin: A Potential Therapeutic Agent in Cardiovascular Disease , 2011, Marine drugs.

[20]  M. Brennan,et al.  Topical nonsteroidal anti-inflammatory drugs for the treatment of pain due to soft tissue injury: diclofenac epolamine topical patch , 2010, Journal of pain research.

[21]  W. Shin,et al.  Pharmacokinetics and first-pass metabolism of astaxanthin in rats , 2010, British Journal of Nutrition.

[22]  B. Mathison,et al.  Effect of astaxanthin supplementation on inflammation and cardiac function in BALB/c mice. , 2010, Anticancer research.

[23]  A. So,et al.  Gout. Mechanisms of inflammation in gout , 2010, Arthritis research & therapy.

[24]  B. Chew,et al.  Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans , 2010, Nutrition & metabolism.

[25]  Kate Schroder,et al.  The NLRP3 Inflammasome: A Sensor for Metabolic Danger? , 2010, Science.

[26]  R. Liu-Bryan.  Intracellular innate immunity in gouty arthritis: role of NALP3 inflammasome , 2010, Immunology and cell biology.

[27]  G. Núñez,et al.  The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis , 2009, Nature Immunology.

[28]  D. Tripathi,et al.  Astaxanthin inhibits cytotoxic and genotoxic effects of cyclophosphamide in mice germ cells. , 2008, Toxicology.

[29]  V. Singh,et al.  The role of nitric oxide in inflammatory reactions. , 2007, FEMS immunology and medical microbiology.

[30]  J. Tschopp,et al.  The role of interleukin-1 and the inflammasome in gout: implications for therapy. , 2007, Arthritis and rheumatism.

[31]  Hyon K. Choi,et al.  Pathogenesis of Gout , 2005, Annals of Internal Medicine.

[32]  M. Hochberg.  COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective. , 2005, Current topics in medicinal chemistry.

[33]  A. Fam.  Treating acute gouty arthritis with selective COX 2 inhibitors , 2002, BMJ : British Medical Journal.

[34]  J. Coleman.  Nitric oxide in immunity and inflammation. , 2001, International immunopharmacology.

[35]  A. Descoteaux,et al.  Cyclooxygenase-2 Expression in Macrophages: Modulation by Protein Kinase C-α1 , 2000, The Journal of Immunology.

[36]  K. Iijima,et al.  Intervention of astaxanthin against cyclophosphamide ‐ induced oxidative stress and DNA damage : a study in mice , 2010 .

[37]  T. Wong,et al.  Dietary beta-carotene and astaxanthin but not canthaxanthin stimulate splenocyte function in mice. , 1999, Anticancer research.

[38]  K. Higashi-Okai,et al.  Possible immunomodulating activities of carotenoids in in vitro cell culture experiments. , 1996, International journal of immunopharmacology.

[39]  N. Schlesinger.  Management of Acute and Chronic Gouty Arthritis , 2012, Drugs.

[40]  D. Salter,et al.  Inhibition of cyclooxygenase 2 expression by diallyl sulfide on joint inflammation induced by urate crystal and IL-1beta. , 2009, Osteoarthritis and cartilage.

[41]  A. Descoteaux,et al.  Cyclooxygenase-2 expression in macrophages: modulation by protein kinase C-alpha. , 2000, Journal of immunology.

[42]  M. Gross,et al.  Effect of carotenoids on in vitro immunoglobulin production by human peripheral blood mononuclear cells: astaxanthin, a carotenoid without vitamin A activity, enhances in vitro immunoglobulin production in response to a T-dependent stimulant and antigen. , 1995, Nutrition and cancer.